Advances in Drug Therapy of Gastrointestinal Ulceration
Andrew Garner, Brendan J. R. Whittle
Wiley, 1989 - Antiulcer drugs - 306 pages
This volume is based on the proceedings of the 38th annual Biological Council Symposium on Drug Action, held at the Royal Institution, London, in April 1988. The conference was addressed by 20 international experts on gastrointestinal ulcers.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Experimental Studies with Histamine H2Receptor Antagonists
Mechanisms of Parietal Cell Function
Experimental Studies with Proton Pump Inhibitors
13 other sections not shown
action activity adherent mucus Allen analogues antacids anti-ulcer antisecretory agents antral bicarbonate secretion cimetidine clinical trials colloidal bismuth cytoprotection doses drugs duodenal ulcer duodenum effect endogenous enprostil enzyme epithelial cells epithelium ethanol Figure Flemström Garner gastric acid gastric acid secretion gastric and duodenal gastric mucosa gastric ulcer gastroduodenal Gastroenterol Gastroenterology glands H2-antagonists H2-receptor antagonists Hawkey healing rates histamine histological increase induced inflammatory bowel disease infusion inhibition inhibitors intestinal intragastric K*-ATPase Konturek lesions leukotrienes lipoxygenase LTB4 lumen luminal mechanisms mediators membrane microsomes misoprostol mucosal mucosal damage mucosal injury mucosal protection mucus mucus barrier mucus gel omeprazole PAF-acether parietal cells patients pepsin PGE2 Pharmacol pharmacological Physiol placebo potential prostaglandins protein pylori ranitidine receptor release role SASP Scand secretory shown Silen stimulation stomach studies sucralfate surface synthesis Szabo therapy thromboxane tissue treatment TXA2 ug kg ulcer healing ulcerative colitis vascular vitro vivo Whittle